These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 7386501)

  • 1. Hyperviscosity syndrome associated with an idiopathic monoclonal IgA-rheumatoid factor.
    Kosaka M; Solomon A
    Am J Med; 1980 Jul; 69(1):145-54. PubMed ID: 7386501
    [No Abstract]   [Full Text] [Related]  

  • 2. A case of rheumatoid hyperviscosity syndrome with characterization of the serum immune complexes.
    Silberman S; Holmes EW; Miller BJ; Messmore HL; Barr WG
    Ann Clin Lab Sci; 1986; 16(1):26-33. PubMed ID: 3947026
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sjögren's syndrome: hyperviscosity and intermediate complexes.
    Blaylock WM; Waller M; Normansell DE
    Ann Intern Med; 1974 Jan; 80(1):27-34. PubMed ID: 4129658
    [No Abstract]   [Full Text] [Related]  

  • 4. Hyperviscosity syndrome in dysproteinemias.
    Buxbaum J
    Am J Med Sci; 1972 Aug; 264(2):123-6. PubMed ID: 4631633
    [No Abstract]   [Full Text] [Related]  

  • 5. Plasmapheresis and chemotherapy of hyperviscosity syndrome associated with monoclonal gammopathy in the dog.
    Matus RE; Leifer CE; Gordon BR; MacEwen EG; Hurvitz AI
    J Am Vet Med Assoc; 1983 Jul; 183(2):215-8. PubMed ID: 6885594
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selective bone marrow involvement of lymphoplasmacytic cells secreting monoclonal IgA rheumatoid factor in a patient with Sjögren's syndrome and serum hyperviscosity.
    Bergonzi C; Merlini GP; Morandi S; Bianchini E; Pavesi F; Bellotti V; Montecucco CM; Ascari E
    Ann Rheum Dis; 1987 Dec; 46(12):938-42. PubMed ID: 3426303
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The hyperviscosity syndrome in rheumatoid arthritis due to intermediate complexes formed by self-association of IgG-rheumatoid factors.
    Pope RM; Mannik M; Gilliland BC; Teller DC
    Arthritis Rheum; 1975; 18(2):97-106. PubMed ID: 1131287
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum hyperviscosity in Sjögren's syndrome interaction between IgG and IgG rheumatoid factor.
    Alarcón-Segovia D; Fishbein E; Abruzzo JL; Heimer R
    Ann Intern Med; 1974 Jan; 80(1):35-42. PubMed ID: 4204033
    [No Abstract]   [Full Text] [Related]  

  • 9. Hyperviscosity syndrome in rheumatoid arthritis.
    Baron M; Fam AG; Elkan I; Underdown B
    J Rheumatol; 1982; 9(6):843-9. PubMed ID: 7161774
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rheumatoid hyperviscosity syndrome.
    Jasin HE; LoSpalluto J; Ziff M
    Am J Med; 1970 Oct; 49(4):484-93. PubMed ID: 4097803
    [No Abstract]   [Full Text] [Related]  

  • 11. Rheumatoid hyperviscosity: analysis of a patient with intermediate complexes that block other autoantibodies and a review of the literature.
    Scofield RH; Tardibono G; Ogden SB; Harley JB; Reichlin M; Kurien BT
    Semin Arthritis Rheum; 1998 Jun; 27(6):382-91. PubMed ID: 9662757
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Polyclonal hyperviscosity syndrome.
    Hadler NM; Gabriel D; Su Chung K; Teague P; Napier MA
    Arthritis Rheum; 1977; 20(7):1388-95. PubMed ID: 911356
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Polymerized monoclonal IgA in tuo patients with myelomatosis and hyperviscosity syndrome.
    Virella G; Preto RV; Graça F
    Br J Haematol; 1975 Aug; 30(4):479-87. PubMed ID: 1201229
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma cell leukemia with IgA paraproteinemia and hyperviscosity.
    Kosmo MA; Gale RP
    Am J Hematol; 1988 Jun; 28(2):113-5. PubMed ID: 3394712
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evidence for a common synthetic origin for secretory and serum IgA.
    Abraham GN; Santucci E; Jacox RF
    Adv Exp Med Biol; 1974; 45(0):233-40. PubMed ID: 4137652
    [No Abstract]   [Full Text] [Related]  

  • 16. AGGREGATION OF IGG GLOBULIN IN VIVO. I. THE HYPERVISCOSITY SYNDROME IN MULTIPLE MYELOMA.
    SMITH E; KOCHWA S; WASSERMAN LR
    Am J Med; 1965 Jul; 39():35-48. PubMed ID: 14314235
    [No Abstract]   [Full Text] [Related]  

  • 17. Hyperviscosity syndrome in IgA multiple myeloma.
    Tuddenham EG; Whittaker JA; Bradley J; Lilleyman JS; James DR
    Br J Haematol; 1974 May; 27(1):65-76. PubMed ID: 4852331
    [No Abstract]   [Full Text] [Related]  

  • 18. Monoclonal IgM rheumatoid factor in a patient with rheumatoid arthritis and hyperviscosity syndrome.
    Rietveld AP; van Paassen HC
    Neth J Med; 1983; 26(6):157-9. PubMed ID: 6412149
    [No Abstract]   [Full Text] [Related]  

  • 19. Studies on IgA antiglobulins in IgA nephropathy.
    Sinico RA; Fornasieri A; Paterna L; Maldifassi P; Benuzzi S; Civardi R; D'Amico G
    Semin Nephrol; 1987 Dec; 7(4):325-8. PubMed ID: 3502193
    [No Abstract]   [Full Text] [Related]  

  • 20. Circulating immune complexes and the treatment of Wegener's granulomatosis.
    Cairns SA; Solomon LR; London RA; Goldby FS; Mallick NP
    Nephron; 1981; 29(1-2):90-4. PubMed ID: 7329481
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.